.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Predict branded drug patent expiration

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
McKesson
Cantor Fitzgerald
Queensland Health
Mallinckrodt
Teva
Dow
Chubb
Novartis
Accenture

Generated: July 23, 2017

DrugPatentWatch Database Preview

Moexipril hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for moexipril hydrochloride and what is the scope of moexipril hydrochloride freedom to operate?

Moexipril hydrochloride
is the generic ingredient in two branded drugs marketed by Teva, Ucb Inc, Glenmark Generics, Chartwell Rx, and Apotex Inc, and is included in five NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for moexipril hydrochloride. Seven suppliers are listed for this compound.

Summary for Generic Name: moexipril hydrochloride

Tradenames:2
Patents:1
Applicants:5
NDAs:5
Drug Master File Entries: see list7
Suppliers / Packagers: see list7
Bulk Api Vendors: see list24
Clinical Trials: see list2,254
Patent Applications: see list1,293
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:moexipril hydrochloride at DailyMed

Pharmacology for Ingredient: moexipril hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chartwell Rx
MOEXIPRIL HYDROCHLORIDE
moexipril hydrochloride
TABLET;ORAL077536-001Nov 30, 2006ABRXNoNo► Subscribe► Subscribe
Glenmark Generics
MOEXIPRIL HYDROCHLORIDE
moexipril hydrochloride
TABLET;ORAL090416-001Mar 30, 2010ABRXNoNo► Subscribe► Subscribe
Ucb Inc
UNIVASC
moexipril hydrochloride
TABLET;ORAL020312-002Apr 19, 1995DISCNNoNo► Subscribe► Subscribe
Teva
MOEXIPRIL HYDROCHLORIDE
moexipril hydrochloride
TABLET;ORAL076204-002May 8, 2003ABRXNoYes► Subscribe► Subscribe
Ucb Inc
UNIVASC
moexipril hydrochloride
TABLET;ORAL020312-001Apr 19, 1995DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: moexipril hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ucb Inc
UNIVASC
moexipril hydrochloride
TABLET;ORAL020312-001Apr 19, 19954,344,949► Subscribe
Ucb Inc
UNIVASC
moexipril hydrochloride
TABLET;ORAL020312-002Apr 19, 19954,344,949► Subscribe
Ucb Inc
UNIVASC
moexipril hydrochloride
TABLET;ORAL020312-002Apr 19, 19954,743,450► Subscribe
Ucb Inc
UNIVASC
moexipril hydrochloride
TABLET;ORAL020312-001Apr 19, 19954,743,450► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Cantor Fitzgerald
Cipla
Novartis
Argus Health
Chubb
QuintilesIMS
Covington
UBS
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot